180 related articles for article (PubMed ID: 1350791)
1. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (II). Antagonistic effect of epinastine on chemical mediators, mainly antihistaminic and anti-PAF effects.
Kamei C; Mio M; Kitazumi K; Tsujimoto S; Yoshida T; Adachi Y; Tasaka K
Immunopharmacol Immunotoxicol; 1992; 14(1-2):207-18. PubMed ID: 1350791
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of epinastine on bronchoconstriction induced by histamine, platelet activating factor and serotonin in guinea pigs and rats.
Tasaka K; Kamei C; Nakamura S
Arzneimittelforschung; 1994 Mar; 44(3):327-9. PubMed ID: 7910745
[TBL] [Abstract][Full Text] [Related]
3. Effect of the new antiallergic drug epinastine on chemical mediator induced bronchoconstrictions in guinea pigs.
Misawa M; Kanai Y
Arzneimittelforschung; 1991 Nov; 41(11):1145-9. PubMed ID: 1725697
[TBL] [Abstract][Full Text] [Related]
4. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (I). Elucidation of the mechanism for histamine release inhibition.
Kamei C; Akagi M; Mio M; Kitazumi K; Izushi K; Masaki S; Tasaka K
Immunopharmacol Immunotoxicol; 1992; 14(1-2):191-205. PubMed ID: 1375955
[TBL] [Abstract][Full Text] [Related]
5. Comparison of anti-allergic activities of the histamine H1 receptor antagonists epinastine, ketotifen and oxatomide in human leukocytes.
Mita H; Shida T
Arzneimittelforschung; 1995 Jan; 45(1):36-40. PubMed ID: 7893266
[TBL] [Abstract][Full Text] [Related]
6. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
7. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
[TBL] [Abstract][Full Text] [Related]
8. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
Tasaka K; Kamei C; Akagi M; Mio M; Shirasaka T; Chokki M
Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
[TBL] [Abstract][Full Text] [Related]
9. Comparison of pharmacological properties of optical isomers and a racemic mixture of epinastine.
Tasaka K; Kamei C; Izushi K; Tsujimoto S; Yoshida T
Arzneimittelforschung; 1991 Mar; 41(3):219-23. PubMed ID: 1714277
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
Hwang SB; Li CL; Lam MH; Shen TY
Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of epinastine on the type II-IV allergic reactions in mice, rats and guinea pigs.
Kamei C; Izushi K; Adachi Y; Shimazawa M; Tasaka K
Arzneimittelforschung; 1991 Nov; 41(11):1150-3. PubMed ID: 1687348
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo studies of the non-sedating antihistamine epinastine.
Fügner A; Bechtel WD; Kuhn FJ; Mierau J
Arzneimittelforschung; 1988 Oct; 38(10):1446-53. PubMed ID: 2461715
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
Crowley HJ; Yaremko B; Selig WM; Janero DR; Burghardt C; Welton AF; O'Donnell M
J Pharmacol Exp Ther; 1991 Oct; 259(1):78-85. PubMed ID: 1656030
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of granulocytes in the lung and skin of guinea pigs. Inhibition by the anti-H1 antiallergic agent epinastine.
Fügner A; Meissner C
Arzneimittelforschung; 1994 Dec; 44(12):1338-42. PubMed ID: 7848354
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of oxatomide on oxygen-radical generation and peptide-leukotriene release from guinea pig eosinophils.
Ohmori K; Manabe H; Akuta-Ohnuma K
Arzneimittelforschung; 1998 Jan; 48(1):43-6. PubMed ID: 9522030
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological profile of UK-74,505, a novel and selective PAF antagonist with potent and prolonged oral activity.
Parry MJ; Alabaster VA; Cheeseman HE; Cooper K; deSouza RN; Keir RF
J Lipid Mediat Cell Signal; 1994 Sep; 10(3):251-68. PubMed ID: 7812676
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological studies on the novel antiallergic drug HQL-79: II. Elucidation of mechanisms for antiallergic and antiasthmatic effects.
Matsushita N; Aritake K; Takada A; Hizue M; Hayashi K; Mitsui K; Hayashi M; Hirotsu I; Kimura Y; Tani T; Nakajima H
Jpn J Pharmacol; 1998 Sep; 78(1):11-22. PubMed ID: 9804057
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
[TBL] [Abstract][Full Text] [Related]
20. In vitro investigations with the histamine H1 receptor antagonist, epinastine (WAL 801 CL), on isolated human allergic effector cells.
Amon U; Gibbs BF; Buss G; Nitschke M
Inflamm Res; 2000 Mar; 49(3):112-6. PubMed ID: 10807498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
